COVID-19 Vaccine Efforts
Current information on our scientific progress to bring forward a vaccine that we hope will demonstrate safety and effectiveness to help protect against the novel coronavirus.
- BioNTech and Pfizer announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates
- Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development
- Pfizer advances battle against COVID-19 on multiple fronts
- Pfizer and BioNTech to Co-Develop Potential COVID-19 Vaccine